This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Syneron's New EPrime™ Device Featured On The Doctors Show As The Latest Super Age Eraser

IRVINE, Calif., Nov. 7, 2011 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS),, the global leader in medical aesthetic products and technology featured a live demonstration of their latest technology, ePrime, on the October 27, 2011 segment of The Doctors.  The audience and viewers of The Doctors witnessed first-hand the ePrime procedure and the immediate post treatment results.

(Logo: )

ePrime stands as the only energy-based dermal remodeling device that delivers energy directly to the dermis boosting the skin's natural production of collagen, elastin and hyaluronic acid. "ePrime is a revolutionary new technology in facial aesthetics that delivers energy directly into the skin to produce a three-dimensional improvement to the topography and volume of the skin," said Mitch Chasin, M.D., Cosmetic Laser Specialist and Medical Director at Reflections Center for Skin and Body in Livingston and Bridgewater, New Jersey.  "What sets the ePrime apart clinically from other energy-based devices is that it not only stimulates the production of new collagen, which is standard in many energy-based devices and even with popular topicals, but it has also been clinically proven to stimulate elastin and hyaluronic acid reproduction – the trinity of natural youth allowing skin to not only look younger, but behave younger too."

For the first time ePrime's proprietary Intelligent Feedback Systems™ (IFS), which measures temperature in real time, allows practitioners to adjust power levels to safely and effectively meet the needs of different skin conditions and all skin types.  This single treatment procedure takes less than an hour to perform under local anesthetic allowing patients to drive home safely post-treatment and return to normal activities within 24 hours.

"At Syneron we work diligently alongside our physician partners to remain at the forefront of cutting-edge applications," said Louis P. Scafuri, Chief Executive Officer of Syneron Medical and Candela Corporation.  "ePrime exemplifies our commitment to innovation as it introduces a new paradigm in controlled precision delivery of energy to a specific target which we believe will spark new and exciting advancements in the field of medical aesthetics for both face and body."

To view The Doctor segment featuring ePrime –

For more information about ePrime and to locate a physician in your area, visit

About Syneron Medical Ltd.

Syneron Medical Ltd. – a company devoted to real technology, real science and real results – is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint.  The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite.  The Company sells its products under two distinct brands, Syneron and Candela.  The Company's aspiration and commitment to innovation expands Syneron's offering beyond medical device into the largest in-demand applications in beauty - skin lightening.  Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US.  The company markets and services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.  Additional information can be found at


1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.96 -2.00%
FB $116.83 0.09%
GOOG $692.31 0.19%
TSLA $244.50 -1.30%
YHOO $36.45 -0.38%


Chart of I:DJI
DOW 17,733.07 -97.69 -0.55%
S&P 500 2,067.96 -7.85 -0.38%
NASDAQ 4,782.0340 -23.2570 -0.48%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs